Current Issue
Implementing the Lab of the Future – Pain or Gain?
Sandra Krause, Lab Engineer, Sanofi
Accelerating HTP Stable Expression of Complex Biologics
Whitney Liu, Ph.D., Principal Scientist, Discovery Biotherapeutics Department, Bristol Mye...
ATMPs from Development to Commercial Manufacturing: A Holistic Organizational Outlook
Robert Dream, Managing Director, HDR Company LLC
Relieving the Pressure of Modern Manufacturing with PAT
Alan Messenger, Sales Director, Optimal Industrial Technologies
Amsphere A3 – Protein A Resin: Anoptimized Media to Minimize the Impact of Elution B...
JSR Life Sciences
Featured Articles
Bringing the Freezing of Biopharmaceuticals in From the Cold
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
View All Featured ArticlesCareers
Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive
Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific
Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here
Jason Rudd, Amgen, Statistical Programming Manager
Inspiring the Next Generation at Bristol Myers Squibb
Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist
A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza
Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development
At Bayer We Foster an Environment of Openness and Understanding Not Pity
Jürgen Schrapp, Bayer, Head of R&D Procurement
The Best Thing About Evotec, Without Question, Is The People
Stuart Flanagan, Evotec, Group Leader
View All Careers ArticlesHeadline News
Gilead’s phase 3 MYR301 study demonstrating longer treatment with Bulevirtide was associated with sustaining undetectability after stopping treatment
Enhertu followed by THP before surgery highlights significant improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial
Novo Nordisk’s releases results from Sogroya REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Material Requirements to Support Gene Therapy Development
Presented by Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn
19th May 2022
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
Real-time Sequencing by FTIR in GMP Oligonucleotide Synthesis
Presented by John-David McElderry, Scientist at Biogen and Dominique Hebrault, Science & Technology Business Development at Mettler-Toledo International, Inc
04th March 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Column Packing Protocol for Amsphere A3
Best Practices for Achieving Virus Safety
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
